Effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as switch strategy in virologically-suppressed patients: real world data from a monocentric cohort.
- Published in:
- Antiviral Therapy, 2024, v. 29, n. 6, p. 1, doi. 10.1177/13596535241306467
- By:
- Publication type:
- Article